PeptiDream Income Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	18,521	46,676	28,712	26,852	9,366
Revenue Growth (YoY)	-60.32%	62.57%	6.93%	186.70%	-19.79%
Cost of Revenue	10,999	12,173	11,494	8,739	2,358
Gross Profit	7,522	34,503	17,218	18,113	7,008
Selling, General & Admin	7,474	8,218	6,673	5,687	2,590
Research & Development	5,023	4,002	3,155	2,915	-
Other Operating Expenses	38.72	543	223	228	-
Operating Expenses	12,536	13,481	10,407	9,271	2,590
Operating Income	-5,013	21,022	6,811	8,842	4,418
Interest Expense	-500.31	-287	-230	-190	-
Interest & Investment Income	242.61	262	6	1	0.28
Earnings From Equity Investments	-41.23	22	-357	-203	-
Currency Exchange Gain (Loss)	-	147	84	187	309.62
Other Non Operating Income (Expenses)	-	-	-1,923	-1,978	46.43
EBT Excluding Unusual Items	-5,312	21,166	4,391	6,659	4,774
Gain (Loss) on Sale of Investments	-	-	-	-	49.18
Gain (Loss) on Sale of Assets	-	-278	-38	-6	-
Pretax Income	-5,312	20,888	4,353	6,653	4,824
Income Tax Expense	-1,563	5,874	1,318	-901	1,217
Net Income	-3,749	15,014	3,035	7,554	3,606
Net Income to Common	-3,749	15,014	3,035	7,554	3,606
Net Income Growth	-	394.69%	-59.82%	109.46%	-18.93%
Shares Outstanding (Basic)	129	130	130	130	129
Shares Outstanding (Diluted)	129	130	130	130	130
Shares Change (YoY)	-0.38%	-0.04%	-0.07%	0.09%	-0.00%
EPS (Basic)	-28.99	115.84	23.40	58.18	27.98
EPS (Diluted)	-28.99	115.68	23.38	58.14	27.78
EPS Growth	-	394.78%	-59.79%	109.29%	-18.91%
Free Cash Flow	-14,920	21,767	11,208	-3,803	5,469
Free Cash Flow Per Share	-115.38	167.71	86.32	-29.27	42.13
Gross Margin	40.62%	73.92%	59.97%	67.45%	74.82%
Operating Margin	-27.07%	45.04%	23.72%	32.93%	47.17%
Profit Margin	-20.24%	32.17%	10.57%	28.13%	38.51%
Free Cash Flow Margin	-80.55%	46.63%	39.04%	-14.16%	58.39%
EBITDA	-2,887	23,270	9,244	10,815	5,051
EBITDA Margin	-15.59%	49.85%	32.20%	40.28%	53.93%
D&A For EBITDA	2,127	2,248	2,433	1,973	633.01
EBIT	-5,013	21,022	6,811	8,842	4,418
EBIT Margin	-27.07%	45.04%	23.72%	32.93%	47.17%
Effective Tax Rate	-	28.12%	30.28%	-	25.24%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.